Nieuwkoop Jeroen bought PURR
December 4, 2025 · Form 4 insider transaction
Nieuwkoop Jeroen bought 31,840 shares of Hyperliquid Strategies Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 34 days after the transaction.
Footnotes
On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 31,840 shares of Common Stock to Mr. Nieuwkoop, a member of Rorschach Capital LLC.